最後更新日期:2026 年 5 月 2 日
【博醫科技有限公司「智透析 IQThrill」隱私權條款】
本應用程式「智透析 IQThrill」(以下稱「本應用程式」)係由博醫科技有限公司(以下稱「本公司」)所提供之軟體服務。使用者下載、安裝、註冊、登入或實際使用本應用程式,即視為已完整閱讀、理解並同意本隱私權條款之全部內容。
本公司就使用者個人資料之蒐集、處理及利用,悉依《個人資料保護法》及相關法規辦理。
本公司因提供本應用程式服務之必要,將蒐集您之醫療相關特種個人資料(包含但不限於透析通路資訊、生理參數紀錄、影像資料等)。依《個人資料保護法》第 6 條第 1 項第 6 款規定,本公司須取得您之書面同意。
您於首次註冊本應用程式時,須勾選「我已閱讀並同意本隱私權條款,並書面同意博醫科技有限公司為提供本應用程式服務之必要範圍內,蒐集、處理、利用本人之醫療相關特種個人資料」之選項,完成電子文件形式之同意(依《電子簽章法》第 4 條規定)。
您得隨時撤回前述同意,撤回後本應用程式之相關功能將無法繼續使用,但不影響撤回前已合法蒐集處理之資料效力。
本公司基於本應用程式之運作需要,得蒐集下列個人資料:
姓名、出生日期、聯絡電話、電子郵件地址。
(註:身分證字號僅於您主動填寫時蒐集,非註冊必要欄位)
血液透析通路資訊、生理參數紀錄(包含但不限於血流速、靜脈壓、透析前後血壓、體重、血紅素、血比容)、通路維護資料、通路設計圖或病灶影像、醫師醫囑、麻醉藥使用紀錄等。
登入紀錄、使用者操作行為、IP 位址、裝置識別資訊、作業系統版本、錯誤紀錄等技術資料。
如使用者拒絕提供前述資料,本應用程式之部分或全部功能將無法正常運作。
本公司蒐集之個人資料,將於下列目的範圍內使用:
本公司不會將個人資料用於與蒐集目的無關之其他用途,亦不會用於行銷推廣或販售。
自您註冊本應用程式之日起,至您刪除帳號或停用本應用程式後依本條款第九項所定期間止;但法令另有保存義務者,依其期間。
主要儲存於台灣境內之伺服器。為提供雲端備份服務,部分加密後之資料可能傳輸至本公司委外之雲端服務供應商所在地。
以自動化或非自動化方式進行蒐集、儲存、處理、傳輸、分析或利用。
為提供本應用程式之完整功能,本公司使用以下第三方服務:
上述供應商均依其各自之隱私政策處理資料,本公司已要求其於合約範圍內使用資料並負保密義務。涉及跨境傳輸時,本公司確保接收國具備充分之資料保護水準。
為保障個人資料安全,本公司採取符合法規要求之技術及管理措施,包括但不限於:
依《個人資料保護法》第 12 條規定,本公司於發生個人資料遭竊取、洩漏、竄改或其他侵害事件時,將於查明事實後,以電子郵件、應用程式內推播或其他適當方式,於合理期間內通知受影響之使用者,並說明事件原因及本公司之因應措施。
依《個人資料保護法》第 3 條、第 10 條及第 11 條等相關規定,您就您之個人資料,得向本公司行使下列權利:
您得透過下列方式行使上述權利:
本公司收到您之請求後,將於 15 日內回覆並依法處理;必要時得延長 15 日,並書面通知您延長原因。
本公司得視營運需要或法令變更隨時修訂本條款。修訂後之內容將於本應用程式內公告,重大變更將另以推播或電子郵件通知。您於變更生效後仍繼續使用本應用程式者,即視為同意修訂內容。
如您對本條款或個人資料相關事宜有疑義,請透過以下方式聯絡本公司:
本條款之解釋及適用,以及您與本公司因本應用程式所生之爭議,均以中華民國法律為準據法,並以台灣[公司所在地]地方法院為第一審管轄法院。
【BroadMed Technology Co., Ltd. — IQThrill Privacy Policy】
This application, "IQThrill" (hereinafter referred to as the "Application"), is a software service provided by BroadMed Technology Co., Ltd. (hereinafter referred to as the "Company"). By downloading, installing, registering, logging in to, or otherwise using the Application, the user is deemed to have fully read, understood, and agreed to all contents of this Privacy Policy.
The Company collects, processes, and uses personal data in accordance with Taiwan's Personal Data Protection Act ("PDPA") and other applicable laws and regulations.
The Company collects medical-related sensitive personal data (including but not limited to vascular access information, physiological parameters, and image data) as necessary for providing the Application's services. Pursuant to Article 6, Paragraph 1, Item 6 of the PDPA, the Company must obtain your written consent.
Upon initial registration, you must check the consent option: "I have read and agreed to this Privacy Policy, and I consent in writing, in accordance with the PDPA, to BroadMed Technology Co., Ltd.'s collection, processing, and use of my medical-related sensitive personal data within the necessary scope of providing the Application's services." This electronic acknowledgment constitutes valid written consent under Taiwan's Electronic Signatures Act, Article 4.
You may withdraw such consent at any time. Upon withdrawal, the Application's relevant functions will become unavailable, but withdrawal does not affect the validity of data already lawfully collected and processed prior to withdrawal.
For the operation of this Application, the Company may collect the following categories of personal data:
Name, date of birth, contact telephone number, email address.
(Note: Government-issued identification number is collected only if you voluntarily provide it; it is not a required field for registration.)
Hemodialysis vascular access information, physiological parameter records (including but not limited to blood flow rate, venous pressure, pre/post-dialysis blood pressure, body weight, hemoglobin, hematocrit), access maintenance records, anatomy diagrams or lesion-related images, physician notes, and anesthesia records.
Login records, user operation behavior, IP address, device identifiers, operating system version, error logs, and other technical information.
If the user refuses to provide the aforementioned data, part or all functions of the Application may not operate properly.
The personal data collected shall be used solely for the following purposes:
The Company shall not use personal data for purposes unrelated to the original purpose of collection, nor for marketing or sale.
From the date of your registration until your account deletion or discontinuation of use, subject to the retention periods specified in Section IX, unless retention is required by applicable laws.
Primarily stored on servers located in Taiwan. For cloud backup services, encrypted data may be transmitted to locations of the Company's outsourced cloud service providers.
By automated or non-automated means for collection, storage, processing, transmission, analysis, or use.
To provide the Application's full functionality, the Company uses the following third-party services:
These providers process data according to their respective privacy policies. The Company requires them to use data only within the contractual scope and to maintain confidentiality. For cross-border transfers, the Company ensures the receiving jurisdiction has adequate data protection standards.
To protect personal data, the Company implements technical and administrative measures compliant with legal requirements, including:
In accordance with Article 12 of the PDPA, in the event of theft, leakage, alteration, or other infringement of personal data, the Company shall, after ascertaining the facts, notify affected users through email, in-app push notifications, or other appropriate means within a reasonable period, and explain the cause of the incident and the Company's response measures.
Pursuant to Articles 3, 10, and 11 of the PDPA, you may exercise the following rights regarding your personal data:
You may exercise these rights through:
The Company will respond within 15 days of receiving your request and process it according to law. Extensions of up to 15 additional days may apply, with written notice of the reason for extension.
The Company may revise this Privacy Policy at any time due to operational needs or changes in laws and regulations. Revised contents shall be announced within the Application; significant changes will be additionally notified via push notification or email. Continued use after the effective date of changes constitutes acceptance of the revised Policy.
For any questions regarding this Policy or personal data matters, please contact:
This Policy and any disputes arising between you and the Company in connection with the Application shall be governed by the laws of the Republic of China (Taiwan), with the [Company location] District Court as the court of first instance.